![Steven Ketchum](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steven Ketchum
Directeur Technique/Scientifique/R&D chez AMARIN CORPORATION PLC
Fortune : 3 M $ au 31/05/2024
Postes actifs de Steven Ketchum
Sociétés | Poste | Début | Fin |
---|---|---|---|
AMARIN CORPORATION PLC | Directeur Technique/Scientifique/R&D | 16/02/2012 | - |
Historique de carrière de Steven Ketchum
Anciens postes connus de Steven Ketchum
Sociétés | Poste | Début | Fin |
---|---|---|---|
VIRACTA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/02/2012 | 24/02/2021 |
Directeur Technique/Scientifique/R&D | 01/06/2008 | 01/02/2012 | |
Independent Dir/Board Member | 01/02/2012 | 24/02/2021 | |
Reliant Pharmaceuticals LLC
![]() Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Directeur Technique/Scientifique/R&D | 01/05/2005 | 01/05/2008 |
IntraBiotics Pharmaceuticals, Inc.
![]() IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | Directeur des opérations | 01/06/2002 | 22/01/2007 |
Conseiller Juridique Général | 01/06/2002 | 22/01/2007 | |
ALZA CORPORATION | Conseiller Juridique Général | 01/11/1994 | 01/05/2002 |
Formation de Steven Ketchum
Stanford University | Undergraduate Degree |
University College London | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Irlande | 2 |
Royaume-Uni | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
General Counsel | 2 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
AMARIN CORPORATION PLC | Health Technology |
Entreprise privées | 4 |
---|---|
IntraBiotics Pharmaceuticals, Inc.
![]() IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | Health Technology |
Sunesis Pharmaceuticals, Inc.
![]() Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Reliant Pharmaceuticals LLC
![]() Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Commercial Services |
ALZA Corp.
![]() ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
- Bourse
- Insiders
- Steven Ketchum
- Expérience